Lauren Riker Biography and Net Worth

VP of Pacira BioSciences

Presently, Lauren Bullaro Riker holds the position of Vice President-Finance at Pacira Biosciences, Inc. Ms. Riker is also on the board of Pacira Ltd.

Ms. Riker received an undergraduate degree from Boston College and an MBA from Columbia University.

What is Lauren Bullaro Riker's net worth?: The estimated net worth of Lauren Bullaro Riker is at least $376,604.20 as of July 5th, 2023. Ms. Riker owns 22,687 shares of Pacira BioSciences stock worth more than $376,604 as of November 17th. This net worth approximation does not reflect any other investments that Ms. Riker may own. Additionally, Ms. Riker receives a salary of $288,810.00 as VP at Pacira BioSciences. Learn More about Lauren Bullaro Riker's net worth.
How old is Lauren Bullaro Riker?: Ms. Riker is currently 45 years old. There are 7 older executives and no younger executives at Pacira BioSciences. The oldest executive at Pacira BioSciences is Mr. David M. Stack, Advisor, who is 74 years old. Learn More on Lauren Bullaro Riker's age.
What is Lauren Bullaro Riker's salary?: As the VP of Pacira BioSciences, Inc., Ms. Riker earns $288,810.00 per year. There are 6 executives that earn more than Ms. Riker. The highest earning executive at Pacira BioSciences is Mr. David M. Stack, Advisor, who commands a salary of $1,540,000.00 per year. Learn More on Lauren Bullaro Riker's salary.
How do I contact Lauren Bullaro Riker?: The corporate mailing address for Ms. Riker and other Pacira BioSciences executives is 5 SYLVAN WAY SUITE 300, PARSIPPANY NJ, 07054. Pacira BioSciences can also be reached via phone at (813) 553-6680 and via email at [email protected]. Learn More on Lauren Bullaro Riker's contact information.
Has Lauren Bullaro Riker been buying or selling shares of Pacira BioSciences?: Lauren Bullaro Riker has not been actively trading shares of Pacira BioSciences during the past quarter. Most recently, Lauren Bullaro Riker sold 643 shares of the business's stock in a transaction on Wednesday, July 5th. The shares were sold at an average price of $38.91, for a transaction totalling $25,019.13. Following the completion of the sale, the senior vice president now directly owns 22,687 shares of the company's stock, valued at $882,751.17. Learn More on Lauren Bullaro Riker's trading history.
Who are Pacira BioSciences' active insiders?: Pacira BioSciences' insider roster includes Donald Manning (Insider), Max Reinhardt (Insider), Charles Reinhart, III (CFO), Lauren Riker (VP), David Stack (CEO), Andreas Wicki (Director), Kristen Williams (Insider), and Roy Winston (Insider). Learn More on Pacira BioSciences' active insiders.
Are insiders buying or selling shares of Pacira BioSciences?: In the last twelve months, Pacira BioSciences insiders bought shares 3 times. They purchased a total of 11,176 shares worth more than $136,240.40. In the last twelve months, insiders at the sold shares 10 times. They sold a total of 113,661 shares worth more than $3,413,175.87. The most recent insider tranaction occured on September, 13th when COO Daryl Gaugler sold 500 shares worth more than $6,430.00. Insiders at Pacira BioSciences own 6.4% of the company. Learn More about insider trades at Pacira BioSciences.
Information on this page was last updated on 9/13/2024.

Lauren Bullaro Riker Insider Trading History at Pacira BioSciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/5/2023	Sell	643	$38.91	$25,019.13	22,687
6/14/2023	Sell	6,366	$38.42	$244,581.72	22,687
6/6/2023	Sell	591	$38.99	$23,043.09	19,669
6/6/2022	Sell	1,150	$61.37	$70,575.50	14,002
3/10/2022	Sell	9,300	$71.22	$662,346.00
1/18/2022	Sell	2,500	$64.97	$162,425.00
7/29/2021	Sell	90	$60.81	$5,472.90
6/11/2021	Sell	2,003	$59.85	$119,879.55	14,734
6/4/2021	Sell	1,047	$61.04	$63,908.88	12,134
3/17/2021	Sell	2,000	$70.01	$140,020.00	14,701
3/15/2021	Sell	1,520	$73.28	$111,385.60	14,701
9/16/2020	Sell	3,000	$60.34	$181,020.00	16,181
8/11/2020	Sell	8,180	$60.50	$494,890.00	20,813
6/29/2020	Sell	6,000	$49.47	$296,820.00	18,633
6/4/2020	Sell	879	$46.33	$40,724.07	9,585
5/21/2020	Sell	2,000	$45.26	$90,520.00	12,464
5/19/2020	Sell	2,000	$42.81	$85,620.00	12,464
2/7/2020	Sell	170	$46.81	$7,957.70	11,294
11/20/2019	Sell	1,176	$44.14	$51,908.64	11,640
11/11/2019	Sell	5,000	$43.59	$217,950.00
6/10/2019	Sell	2,126	$44.28	$94,139.28	10,042
6/4/2019	Sell	967	$42.91	$41,493.97
11/2/2018	Sell	1,000	$54.35	$54,350.00	11,474
9/24/2018	Sell	1,000	$50.70	$50,700.00	11,474
8/22/2018	Sell	1,667	$44.48	$74,148.16	10,474
6/4/2018	Sell	801	$33.02	$26,449.02	9,641
12/15/2017	Sell	340	$43.70	$14,858.00
6/5/2017	Sell	601	$43.32	$26,035.32
6/7/2016	Sell	938	$47.66	$44,705.08	5,945
6/6/2016	Sell	321	$47.20	$15,151.20	5,945
3/16/2015	Sell	5,000	$95.34	$476,700.00

Lauren Bullaro Riker Buying and Selling Activity at Pacira BioSciences

Pacira BioSciences Company Overview

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

Today's Range

Now: $16.60

$16.21

$16.66

50 Day Range

MA: $15.81

$12.73

$17.70

2 Week Range

Now: $16.60

$11.16

$35.95

Volume

780,465 shs

Average Volume

535,337 shs

Market Capitalization

$766.42 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.82

The only candlestick pattern worth a darn

From WealthPress | Ad

It’s widely known that 80% of daily market action is driven by Wall Street algorithms… Now, most people think of the algorithms are “bad” When in reality, they are neither good nor bad… They are simply programmed to buy and sell certain stocks over and over again… But here is the thing… They are predictable… They typically buy the same stocks at the same levels over and over again…

Follow this link here and enter your email address to sign up…

Lauren Riker Biography and Net Worth

What is Lauren Bullaro Riker's net worth?

How old is Lauren Bullaro Riker?

What is Lauren Bullaro Riker's salary?

How do I contact Lauren Bullaro Riker?

Has Lauren Bullaro Riker been buying or selling shares of Pacira BioSciences?

Who are Pacira BioSciences' active insiders?

Are insiders buying or selling shares of Pacira BioSciences?